DBV Technologies price target raised to $7 from $4 at Goldman Sachs

Goldman Sachs analyst Graig Suvannavejh raised the firm's price target on DBV Technologies (DBVT) to $7 from $4 and keeps a Buy rating on the shares after the company announced an update on the U.S. regulatory status of lead asset Viaskin Peanut. The stock closed Friday up 51% to $5.66. The analyst came away "increasingly positive" given the clarity gained on the forward, and continues to have confidence in the ultimate approvability of Viaskin Peanut in the U.S. and its commercial potential. Viaskin Peanut is the more attractive and easier product to administer relative to its main competition, Nestle's (NSRGY) Palforzia, Suvannavejh tells investors in a research note.